Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Law

Showing results (221-230 of 341) with videos related to

Pageof 35
Sort By:
BMC Infectious Diseases|December 2, 2017
Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance dataDavid C Boettiger, Matthew G Law, Gregory J Dore, et al.
The Journal of Surgical Research|October 17, 2007
Adenosine A2A activation attenuates nontransplantation lung reperfusion injuryPeter I Ellman, T Brett Reece, Marianna G Law, et al.
Nutrients|October 16, 2025
Lipoprotein(a) Lipidome: Responses to Reduced Dietary Saturated Fat Intake in Two Randomized Controlled Feeding TrialsMunkhtuya Myagmarsuren, Hayley G Law, Wei Zhang, et al.
Journal of Lipid Research|July 5, 2024
Lipoprotein(a) and diet: consuming sugar-sweetened beverages lowers lipoprotein(a) levels in obese and overweight adultsHayley G Law, Kimber L Stanhope, Wei Zhang, et al.
AIDS (London, England)|April 21, 2011
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settingsKaren Schneider, Thanyawee Puthanakit, Stephen Kerr, et al.
The Medical Journal of Australia|April 19, 2011
Predictors of deferral of treatment for hepatitis C infection in Australian clinicsHeather F Gidding, Matthew G Law, Janaki Amin, et al.
AIDS (London, England)|May 23, 2012
Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individualsAmit C Achhra, Janaki Amin, Caroline Sabin, et al.
Antiviral Therapy|November 8, 2014
Loss to follow-up in the Australian HIV Observational DatabaseHamish McManus, Kathy Petoumenos, Katherine Brown, et al.
International Journal of Clinical Practice|October 15, 2013
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trialJ P H Wilding, G Charpentier, P Hollander, et al.
Diabetes, Obesity & Metabolism|June 27, 2014
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney diseaseJ-F Yale, G Bakris, B Cariou, et al.
Pageof 35

Showing results (221-230 of 341) with videos related to

Sort By:
Pageof 35
BMC Infectious Diseases|December 2, 2017
Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance dataDavid C Boettiger, Matthew G Law, Gregory J Dore, et al.
The Journal of Surgical Research|October 17, 2007
Adenosine A2A activation attenuates nontransplantation lung reperfusion injuryPeter I Ellman, T Brett Reece, Marianna G Law, et al.
Nutrients|October 16, 2025
Lipoprotein(a) Lipidome: Responses to Reduced Dietary Saturated Fat Intake in Two Randomized Controlled Feeding TrialsMunkhtuya Myagmarsuren, Hayley G Law, Wei Zhang, et al.
Journal of Lipid Research|July 5, 2024
Lipoprotein(a) and diet: consuming sugar-sweetened beverages lowers lipoprotein(a) levels in obese and overweight adultsHayley G Law, Kimber L Stanhope, Wei Zhang, et al.
AIDS (London, England)|April 21, 2011
Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settingsKaren Schneider, Thanyawee Puthanakit, Stephen Kerr, et al.
The Medical Journal of Australia|April 19, 2011
Predictors of deferral of treatment for hepatitis C infection in Australian clinicsHeather F Gidding, Matthew G Law, Janaki Amin, et al.
AIDS (London, England)|May 23, 2012
Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individualsAmit C Achhra, Janaki Amin, Caroline Sabin, et al.
Antiviral Therapy|November 8, 2014
Loss to follow-up in the Australian HIV Observational DatabaseHamish McManus, Kathy Petoumenos, Katherine Brown, et al.
International Journal of Clinical Practice|October 15, 2013
Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trialJ P H Wilding, G Charpentier, P Hollander, et al.
Diabetes, Obesity & Metabolism|June 27, 2014
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney diseaseJ-F Yale, G Bakris, B Cariou, et al.
Pageof 35